About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalNJ, NY, PA
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
13
As Collaborator
0
Total Enrollment
430
By Phase
PHASE1/PHASE2: 2PHASE2: 6PHASE1: 5
By Status
COMPLETED: 9TERMINATED: 3RECRUITING: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06315738Lead Sponsor
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis
PHASE1/PHASE2Recruiting
36 participants
Started: Aug 19, 2024 · Completed: Nov 30, 2029
NCT05066698Lead Sponsor
ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects
PHASE2Terminated
8 participants
Started: Apr 27, 2022 · Completed: Sep 7, 2022
NCT04720378Lead Sponsor
Safety and Tolerability Study of IV ST266 in COVID-19 Subjects
PHASE1Completed
12 participants
Started: May 30, 2021 · Completed: May 3, 2022
NCT03901781Lead Sponsor
Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects
PHASE1Completed
9 participants
Started: Oct 23, 2019 · Completed: May 20, 2022
NCT03687632Lead Sponsor
ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects
PHASE2Completed
13 participants
Started: Jun 10, 2019 · Completed: Aug 25, 2020
Locations (1)
Headquarters
Pittsburgh, PA, United States
Map
Loading map...